Purpose: To analyze feasibility and toxicity of radical hypofractionated RT schedules in elderly patients with NSCLC Material and Methods: Material and methods: Elderly patients ( ≥70 years old) affected by stage III inoperable NSCLC were treated in our institution with radical IMRT (VMAT RA) according to moderately hypofractionated schedules: 56 Gy/20 fractions or 55 Gy/22 fractions or 50 Gy/20 fractions depending on dose constraints of adjacent organs at risk. Patients underwent simulation CT in supine position, immobilized with a thermoplastic mask. PET CT was performed for simulation and coregistered with CT. Primary end point of this analysis were acute and late toxixcities, secondary end points were local control and overall survival.
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Purpose: To analyze feasibility and toxicity of radical hypofractionated RT schedules in elderly patients with NSCLC Material and Methods: Material and methods: Elderly patients ( ≥70 years old) affected by stage III inoperable NSCLC were treated in our institution with radical IMRT (VMAT RA) according to moderately hypofractionated schedules: 56 Gy/20 fractions or 55 Gy/22 fractions or 50 Gy/20 fractions depending on dose constraints of adjacent organs at risk. Patients underwent simulation CT in supine position, immobilized with a thermoplastic mask. PET CT was performed for simulation and coregistered with CT. Primary end point of this analysis were acute and late toxixcities, secondary end points were local control and overall survival.
Results:
Results: 41 patients, treated between January 2013 and April 2015, were included in this analysis. Mean age was 78.59 years (range 70-86). 22 patients were staged IIIA, 19 patients IIIB. All but one patients had pathological nodal involvement (N1:5, N2: 24, N3: 11). Most of patients were unsuitable for chemotherapy for comorbidities and poor general conditions. 15 patients received chemotherapy before RT, concomitant RT-CHT was not allowed. Acute G1-2 toxicity was recorded in 25 patients(61), mostly esophagitis, dyspnea and dry cough. Late toxicity was recorded in 13 patients, the most reported side effects were pneumonitis and dyspnea. No G3 or G4 acute or late toxicity were recorded. A complete response was obtained in two patients, 26 showed a partial response, while progressive disease was recorded in 2 cases. At time of analysis, with a mean follow up of 9.89 months (range 1.08-25.43), 17 patients died for disease progression, one patient died for other causes, 8 patients were alive with distant metastases and 15 were alive without distant progression. Actuarial OS at 1 and 2 years were 51.3% and 35.1% respectively. Mean estimated OS was 15.12 months (range 12.02-18.22). Actuarial local control at 1 and 2 years were 72%. 10 patients experienced local progression. Mean estimated LC was 12.4 months (range 9.6-15.1).
Conclusion:
Conclusion: Radical hypofractionated IMRT (VMAT RA) is a valid treatment for locally advanced inoperable NSCLC in elderly frail patients . Our study shows that this approach is safe and feasible also in a fragile elder population. Survival data are satisfactory.
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